451
Last Update Posted: 2013-01-29
Recruiting has ended
All Genders accepted | 18 Years-65 Years |
198 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Drug Therapy for Alcohol Dependence in Alaska Natives (Naltrexone/Sertraline)
This study will assess the ability of naltrexone (Revia) to reduce the risk of relapse in Alaska natives with alcohol dependence. The study will also examine whether a combination of naltrexone and sertraline (Zoloft) yields better abstinence rates than naltrexone used alone. Alaska Native individuals will be recruited into a 16 week outpatient study.
Eligibility
Relevant conditions:
Alcoholism
Alcohol Dependence
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Contact Information
Overall Contact
No valid contacts available
Data sourced from ClinicalTrials.gov